Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr₹-439 Cr

What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Investing Activities ratio of MANKIND PHARMA is ₹-2,082 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹-2,082 Cr
Mar2023₹-1,054 Cr
Mar2022₹-1,369 Cr
Mar2021₹-1,222 Cr
Mar2020₹-439 Cr

How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹-2,082 Cr
Negative
Mar2023 ₹-1,054 Cr
Negative
Mar2022 ₹-1,369 Cr
Negative
Mar2021 ₹-1,222 Cr
Negative
Mar2020 ₹-439 Cr -

Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses